Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
Market capitalization of Intercept Pharmaceuticals (ICPT)
Market cap: $0.79 Billion
As of April 2024 Intercept Pharmaceuticals has a market cap of $0.79 Billion. This makes Intercept Pharmaceuticals the world's 5411th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Intercept Pharmaceuticals from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.79 B | 0% |
| 2023 | $0.79 B | 55.11% |
| 2022 | $0.51 B | 6.44% |
| 2021 | $0.48 B | -40.94% |
| 2020 | $0.81 B | -79.98% |
| 2019 | $4.07 B | 36.03% |
| 2018 | $2.99 B | 104.09% |
| 2017 | $1.46 B | -45.6% |
| 2016 | $2.69 B | -26.01% |
| 2015 | $3.64 B | 9.04% |
| 2014 | $3.34 B | 152.34% |
| 2013 | $1.32 B | 133.96% |
| 2012 | $0.56 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $697.39 B | 87,656.59% | 🇺🇸 USA |
 Gilead Sciences GILD | $81.57 B | 10,165.18% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.90 B | 11,338.39% | 🇺🇸 USA |
 MediciNova MNOV | $64.25 M | -91.92% | 🇺🇸 USA |